hubert jacob paul schoemaker march january dutch biotechnologist cofounder president one americas first biotechnology companies centocor founded commercialising monoclonal antibodies founded neuronyx inc manufacture stem cells development stemcell schoemaker born deventer netherlands attended st bernardus school deventer canisius college nijmegen moved united states attend university notre dame majored chemistry graduating may soon married ann earned doctorate biochemistry massachusetts institute technology supervised paul schimmel doctoral research investigation structure function relationships transfer rnas declining postdoctoral research positions stanley cohen klaus weber schoemaker chose work research scientist industry choice influenced severe disabilities suffered first daughter maureen born lissencephaly needed specialised care inspired schoemaker become involved commercial schoemaker joined corning medical bostonbased division corning glass works corning schoemaker rapidly progressed specialist immunoassay development diagnostics heading research development among achievements company devising effective diagnostic kit tests thyroid schoemaker became involved founding centocor together former corning medical colleague ted allen bioentrepreneur michael wall dealings inspired work hilary koprowski developed earliest monoclonal antibodies tumour antigens influenza viral antigens objective centocor commercialise monoclonal antibodies diagnostics schoemaker joined centocor soon became first chief executive start centocor decided fill product pipeline partnerships research institutions marketing alliances central policy schoemakers ability network companys decision design diagnostic kits compatible existing diagnostic systems schoemakers leadership centocor rapidly grew profitable diagnostic business company revenues approximately million part success built upon swift approval company two tests first gastrointestinal cancer test hepatitis b centocor introduced three diagnostic tests market one ovarian cancer first diagnostic test available disease one breast cancer one colorectal despite companys success diagnostic front schoemaker plunged efforts save company bankruptcy first therapeutic centoxin drug designed treat septic shock failed win fda part crisis come result companys executives trying go alone developing drug saved company return policy collaboration learning mistakes centoxin december centocor gained marketing approval reopro monoclonal antibody drug cardiovascular disease first therapeutic ever receive simultaneous us european approvals second monoclonal antibody ever win approval drug reopro marked milestone centocor monoclonal antibodies therapeutics reopro followed august approval centocors remicade drug treat autoimmune disorders like crohns disease rheumatoid selling centocor johnson johnson schoemaker went form neuronyx inc biotech company focused developing cellular therapies schoemaker died company continued wife anne faulkner schoemaker initial work focused using stem cells taken adult bone marrow help regenerate heart tissue damaged heart later company turned direction looking development treatment incision wounds women following breast cancer reconstruction surgery company later changed name garnet despite promising clinical results raising million venture capital funding company unable schoemaker diagnosed form brain cancer died january age httpsenwikipediaorgwikihubertschoemaker